Could a vitamin e derivative boost chemo and cut side effects in advanced colon cancer?
NCT ID NCT04245865
First seen Apr 06, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at whether adding tocotrienol (a compound related to vitamin E) to standard chemotherapy and bevacizumab can help people with metastatic colorectal cancer. About 83 participants will receive either tocotrienol or a placebo for up to six months. The main goal is to see if more patients stay progression-free at six months, while also checking for side effects and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Oncology, Vejle Hospital
Vejle, 7100, Denmark
Conditions
Explore the condition pages connected to this study.